ArchPoint Investors’s Aimmune Therapeutics, Inc. AIMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-112,099
Closed -$2.51M 141
2019
Q1
$2.51M Buy
+112,099
New +$2.51M 0.75% 26